An interventional study of Manual Lymphatic Drainage in Fibromyalgia, sponsored by Camilo Jose Cela University. Completed at 1 site in Spain. Open to female participants aged 30 Years to 55 Years. Per ClinicalTrials.gov, last updated 2023-08-31.
Sponsored by Camilo Jose Cela University · Not applicable, Interventional, and Treatment
Manual Lymphatic Drainage is a widely used technique for lymphedema. However, the analgesic effects of this technique could be potentially useful for managing pain in patients with generalized widespread chronic pain, including patients with fibromyalgia.
1,336 studies on the registry are indexed under Fibromyalgia; 266 are open to participants now.
This study's enrollment of 30 is below the median of 60 across 1,035 interventional studies indexed under Fibromyalgia.
Browse Fibromyalgia studies →Camilo Jose Cela University is the lead sponsor of 22 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Manual Lymphatic Drainage
Manual lymphatic drainage is a technique that through gentle passes facilitates the flow of lymph through manual therapy techniques based on Vodder therapy. This technique is being studied to know its effectiveness in pain and for this reason we want to carry out this research.
Pain pressure threshold
Kg/cm2
Time frame: Baseline
Pain pressure threshold
Kg/cm2
Time frame: Immediately after the intervention
Pain pressure threshold
Kg/cm2
Time frame: Up to 15 days
Visual Analogue Scale
0-10
Time frame: Baseline
Visual Analogue Scale
0-10
Time frame: Immediately after the intervention
Visual Analogue Scale
0-10
Time frame: Up to 15 days
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Aug 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Camilo Jose Cela University